![]() | Up a level |
Journal Article
Scheiner, Bernhard ORCID: 0000-0002-4904-5133, Pomej, Katharina
ORCID: 0000-0002-2807-3565, Kirstein, Martha M., Hucke, Florian
ORCID: 0000-0001-7887-3440, Finkelmeier, Fabian, Waidmann, Oliver, Himmelsbach, Vera, Schulze, Kornelius, von Felden, Johann
ORCID: 0000-0003-2839-5174, Frundt, Thorben W., Stadler, Marc, Heinzl, Harald, Shmanko, Kateryna, Spahn, Stephan, Radu, Pompilia, Siebenhuener, Alexander R., Mertens, Joachim C., Rahbari, Nuh N., Kuetting, Fabian, Waldschmidt, Dirk-Thomas, Ebert, Matthias P., Teufel, Andreas, De Dosso, Sara, Pinato, David J., Pressiani, Tiziana
ORCID: 0000-0001-6919-1536, Meischl, Tobias, Balcar, Lorenz
ORCID: 0000-0002-6708-3061, Mueller, Christian, Mandorfer, Mattias, Reiberger, Thomas
ORCID: 0000-0002-4590-3583, Trauner, Michael
ORCID: 0000-0002-1275-6425, Personeni, Nicola
ORCID: 0000-0002-7995-272X, Rimassa, Lorenza
ORCID: 0000-0001-9957-3615, Bitzer, Michael
ORCID: 0000-0002-4463-8263, Trojan, Joerg, Weinmann, Arndt, Wege, Henning, Dufour, Jean-Francois, Peck-Radosavljevic, Markus, Vogel, Arndt and Pinter, Matthias
(2022).
Prognosis of patients with hepatocellular carcinoma treated with immunotherapy - development and validation of the CRAFITY score.
J. Hepatol., 76 (2).
S. 353 - 365.
AMSTERDAM:
ELSEVIER.
ISSN 1600-0641
Sinner, Friedrich ORCID: 0000-0003-0524-8833, Pinter, Matthias
ORCID: 0000-0002-7260-532X, Scheiner, Bernhard
ORCID: 0000-0002-4904-5133, Ettrich, Thomas Jens, Sturm, Niklas
ORCID: 0000-0001-9219-0099, Gonzalez-Carmona, Maria A., Waidmann, Oliver, Finkelmeier, Fabian
ORCID: 0000-0001-8559-9910, Himmelsbach, Vera, De Toni, Enrico N., Ben Khaled, Najib, Mohr, Raphael
ORCID: 0000-0003-2403-4275, Fruendt, Thorben Wilhelm, Kuetting, Fabian, van Boemmel, Florian, Lieb, Sabine, Krug, Sebastian
ORCID: 0000-0003-1672-7995, Bettinger, Dominik
ORCID: 0000-0002-8782-8729, Schultheiss, Michael, Jochheim, Leonie S., Best, Jan, Mueller, Christian
ORCID: 0000-0002-6881-1817, Keitel, Verena and Venerito, Marino
ORCID: 0000-0001-8581-0974
(2022).
Atezolizumab Plus Bevacizumab in Patients with Advanced and Progressing Hepatocellular Carcinoma: Retrospective Multicenter Experience.
Cancers, 14 (23).
BASEL:
MDPI.
ISSN 2072-6694